These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21123337)

  • 1. Disease activity monitoring in rheumatoid arthritis in daily practice: experiences with METEOR, a free online tool.
    Koevoets R; Allaart CF; van der Heijde DM; Huizinga TW
    J Rheumatol; 2010 Dec; 37(12):2632-3. PubMed ID: 21123337
    [No Abstract]   [Full Text] [Related]  

  • 2. Rheumatoid arthritis: is the disease becoming milder or is treatment improving?
    Walji S; Bykerk VP
    J Rheumatol; 2004 Jun; 31(6):1023-5. PubMed ID: 15170908
    [No Abstract]   [Full Text] [Related]  

  • 3. Is the outcome of rheumatoid arthritis changed with the use of new disease-modifying antirheumatic drugs?
    Kremer J
    Arthritis Rheum; 2005 Oct; 53(5):636-8. PubMed ID: 16208649
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity.
    Kerr GS; Sabahi I; Richards JS; Caplan L; Cannon GW; Reimold A; Thiele GM; Johnson D; Mikuls TR
    J Rheumatol; 2011 Jan; 38(1):53-9. PubMed ID: 20952475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid arthritis treatment and monitoring of outcomes--where are we [corrected] in 2007?
    Yazici Y; Abramson SB
    Bull NYU Hosp Jt Dis; 2007; 65(4):300-5. PubMed ID: 18081549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic monitoring of disease activity using an outcome measure improves outcomes in rheumatoid arthritis.
    Katchamart W; Bombardier C
    J Rheumatol; 2010 Jul; 37(7):1411-5. PubMed ID: 20436069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The measure of our measures.
    Harth M; Pope J
    Rheumatology (Oxford); 2004 Dec; 43(12):1465-7. PubMed ID: 15479755
    [No Abstract]   [Full Text] [Related]  

  • 8. How should rheumatoid arthritis disease activity be measured today and in the future in clinical care?
    Sokka T
    Rheum Dis Clin North Am; 2010 May; 36(2):243-57. PubMed ID: 20510232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily practice effectiveness of a step-down treatment in comparison with a tight step-up for early rheumatoid arthritis.
    Verschueren P; Esselens G; Westhovens R
    Rheumatology (Oxford); 2008 Jan; 47(1):59-64. PubMed ID: 18039681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potential pitfall in the use of the Disease Activity Score (DAS28) as the main response criterion in treatment guidelines for patients with rheumatoid arthritis.
    Gardiner PV; Bell AL; Taggart AJ; Wright G; Kee F; Smyth A; McKane R; Lee J; Rooney ME; Whitehead E
    Ann Rheum Dis; 2005 Mar; 64(3):506-7. PubMed ID: 15708909
    [No Abstract]   [Full Text] [Related]  

  • 11. Measures of rheumatoid arthritis disease activity.
    Kirwan J
    J Rheumatol; 2009 Feb; 36(2):442-3; author reply 443-4. PubMed ID: 19208571
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment and management of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of severe synovial arthritis with drugs].
    Korpela M
    Duodecim; 2004; 120(6):707-14. PubMed ID: 15119232
    [No Abstract]   [Full Text] [Related]  

  • 14. Whither the ACR20?
    Felson DT
    J Rheumatol; 2004 May; 31(5):835-7. PubMed ID: 15124237
    [No Abstract]   [Full Text] [Related]  

  • 15. Using disease activity measures in an office-based practice.
    Bergman MJ
    J Clin Rheumatol; 2010 Mar; 16(2):96-7. PubMed ID: 20216131
    [No Abstract]   [Full Text] [Related]  

  • 16. A decrease in disease activity score (DAS) level is associated with a decrease in health assessment questionnaire (HAQ) score, independent of follow-up duration, during 5 years of tightly controlled treatment: results from the BeSt study.
    van der Kooi E; Klarenbeek NB; Güler-Yüksel M; Kerstens PJ; van der Lubbe PA; Westedt ML; ten Wolde S; Huizinga TW; Dijkmans BA; Allaart CF
    Ann Rheum Dis; 2011 Jan; 70(1):168-71. PubMed ID: 21115551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How aggressive should initial therapy for rheumatoid arthritis be?
    Pincus T; Sokka T
    Rheumatology (Oxford); 2005 Jan; 44(1):133-4; author reply 135-6. PubMed ID: 15611309
    [No Abstract]   [Full Text] [Related]  

  • 18. Key randomized trials of single agents in early rheumatoid arthritis.
    van de Putte LB
    J Rheumatol Suppl; 2002 Nov; 66():13-9. PubMed ID: 12435164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Just released from the ASAS factory! First steps towards a disease activity score for ankylosing spondylitis.
    Boers M
    Ann Rheum Dis; 2009 Jan; 68(1):1-2. PubMed ID: 19088258
    [No Abstract]   [Full Text] [Related]  

  • 20. Rheumatoid arthritis: time for trials of therapeutic targets.
    Edmonds J; Lassere M
    J Rheumatol; 2002 Oct; 29(10):2041-4. PubMed ID: 12375309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.